These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11237555)

  • 21. Sex-linked differences in susceptibility of cynomolgus monkeys to type II collagen-induced arthritis. Evidence that epitope-specific immune suppression is involved in the regulation of type II collagen autoantibody formation.
    Terato K; Arai H; Shimozuru Y; Fukuda T; Tanaka H; Watanabe H; Nagai Y; Fujimoto K; Okubo F; Cho F
    Arthritis Rheum; 1989 Jun; 32(6):748-58. PubMed ID: 2472147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
    J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance.
    Lu Y; Xiao J; Wu ZW; Wang ZM; Hu J; Fu HZ; Chen YY; Qian RQ
    Phytomedicine; 2012 Jul; 19(10):882-9. PubMed ID: 22673798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible role of peripheral CD14low monocytes in the development of collagen-induced arthritis in cynomolgus monkeys (Macaca fascicularis).
    Terao K; Fujimoto K; Shimozuru Y; Nagai Y; Yoshikawa Y
    Exp Anim; 2001 Jan; 50(1):9-18. PubMed ID: 11326430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CGP 47969A: effect on collagen induced arthritis in DBA/1 mice.
    Geiger T; Rordorf C; Cosenti-Vargas A; Ferrini PG; Widler L; Glatt M; Vosbeck K
    J Rheumatol; 1994 Nov; 21(11):1992-7. PubMed ID: 7869300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice.
    Sasai M; Saeki Y; Ohshima S; Nishioka K; Mima T; Tanaka T; Katada Y; Yoshizaki K; Suemura M; Kishimoto T
    Arthritis Rheum; 1999 Aug; 42(8):1635-43. PubMed ID: 10446862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.
    Cuzzocrea S; Mazzon E; Bevilaqua C; Costantino G; Britti D; Mazzullo G; De Sarro A; Caputi AP
    Br J Pharmacol; 2000 Dec; 131(7):1399-407. PubMed ID: 11090113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of deer antler aqua-acupuncture, the pilose antler of Cervus Korean TEMMINCK var mantchuricus Swinhoe, on type II collagen-induced arthritis in rats.
    Kim YK; Kim KS; Chung KH; Kim JG; Kim KS; Lee YC; Chang YC; Kim CH
    Int Immunopharmacol; 2003 Jul; 3(7):1001-10. PubMed ID: 12810357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis.
    Yokota S; Miyamae T; Imagawa T; Iwata N; Katakura S; Mori M; Woo P; Nishimoto N; Yoshizaki K; Kishimoto T
    Arthritis Rheum; 2005 Mar; 52(3):818-25. PubMed ID: 15751095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.
    Mindrescu C; Thorbecke GJ; Klein MJ; Vilcek J; Wisniewski HG
    Arthritis Rheum; 2000 Dec; 43(12):2668-77. PubMed ID: 11145024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis.
    Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Britti D; De Maio M; Caputi AP
    Eur Cytokine Netw; 2001; 12(4):568-80. PubMed ID: 11781183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis.
    Higuchi K; Kweon MN; Fujihashi K; McGhee JR; Kiyono H
    J Rheumatol; 2000 Apr; 27(4):1038-44. PubMed ID: 10782834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of in vitro responses to type II collagen by splenocytes from arthritic BALB/c mice is possibly caused by intrinsic CD25+ regulatory cells.
    Bäckström F; Dahlgren U
    Scand J Immunol; 2008 Apr; 67(4):362-9. PubMed ID: 18248529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice.
    Yoshino S; Ohsawa M
    Br J Pharmacol; 2000 Apr; 129(7):1309-14. PubMed ID: 10742285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody.
    Yamamoto N; Nakashima T; Torikai M; Naruse T; Morimoto J; Kon S; Sakai F; Uede T
    Int Immunopharmacol; 2007 Nov; 7(11):1460-70. PubMed ID: 17761350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with T cell receptor V beta chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice.
    Haqqi TM; Qu XM; Anthony D; Ma J; Sy MS
    J Clin Invest; 1996 Jun; 97(12):2849-58. PubMed ID: 8675697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant.
    Hess H; Gately MK; Rüde E; Schmitt E; Szeliga J; Germann T
    Eur J Immunol; 1996 Jan; 26(1):187-91. PubMed ID: 8566065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technology evaluation: MRA, Chugai.
    Ding C; Jones G
    Curr Opin Mol Ther; 2003 Feb; 5(1):64-9. PubMed ID: 12669473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-6 functions in cynomolgus monkeys blocked by a humanized antibody to human IL-6 receptor.
    Imazeki I; Saito H; Hasegawa M; Shinkura H; Kishimoto T; Ohsugi Y
    Int J Immunopharmacol; 1998 Jul; 20(7):345-57. PubMed ID: 9756130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.